These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9147276)

  • 1. Differential killer toxin sensitivity patterns of varieties of Cryptococcus neoformans.
    Boekhout T; Scorzetti G
    J Med Vet Mycol; 1997; 35(2):147-9. PubMed ID: 9147276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typing and patterns of cellular morphological alterations in Cryptococcus neoformans and Cryptococcus gattii isolates exposed to a panel of killer yeasts.
    Fuentefria AM; Faganello J; Pazzini F; Schrank A; Valente P; Vainstein M
    Med Mycol; 2007 Sep; 45(6):503-12. PubMed ID: 17710619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela.
    Calvo BM; Colombo AL; Fischman O; Santiago A; Thompson L; Lazera M; Telles F; Fukushima K; Nishimura K; Tanaka R; Myiajy M; Moretti-Branchini ML
    J Clin Microbiol; 2001 Jun; 39(6):2348-50. PubMed ID: 11376089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The green colour effect (GCE) of the killer strain Cryptococcus laurentii CBS 139 on Staib agar.
    Staib F
    Mycoses; 1999 Apr; 42(1-2):103-6. PubMed ID: 10394857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents.
    Poonwan N; Mikami Y; Poosuwan S; Boon-Long J; Mekha N; Kusum M; Yazawa K; Tanaka R; Nishimura K; Konyama K
    Eur J Epidemiol; 1997 Apr; 13(3):335-40. PubMed ID: 9258534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular typing of Cryptococcus neoformans: taxonomic and epidemiological aspects.
    Boekhout T; van Belkum A; Leenders AC; Verbrugh HA; Mukamurangwa P; Swinne D; Scheffers WA
    Int J Syst Bacteriol; 1997 Apr; 47(2):432-42. PubMed ID: 9103633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan.
    Chen YC; Chang SC; Shih CC; Hung CC; Luhbd KT; Pan YS; Hsieh WC
    Diagn Microbiol Infect Dis; 2000 Mar; 36(3):175-83. PubMed ID: 10729660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility characteristics of Cryptococcus neoformans varieties from AIDS patients in Goiânia, Brazil.
    de F L Fernandes O; Passos XS; Souza LK; Miranda AT; Cerqueira CH; Silva Mdo R
    Mem Inst Oswaldo Cruz; 2003 Sep; 98(6):839-41. PubMed ID: 14595465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.
    Dromer F; Gueho E; Ronin O; Dupont B
    J Clin Microbiol; 1993 Feb; 31(2):359-63. PubMed ID: 8432823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
    Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
    Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization of Cryptococcus neoformans strains isolated from patients with acquired immunodeficiency syndrome (AIDS)].
    Garza-Garza D; Buendía-Uribe JL; Martínez-Cruz E; Argüero-Licea B
    Rev Latinoam Microbiol; 1995; 37(3):273-9. PubMed ID: 8850346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.
    Nascimento E; Vitali LH; Kress MRVZ; Martinez R
    Rev Inst Med Trop Sao Paulo; 2017; 59():e49. PubMed ID: 28793019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole-resistant Cryptococcus neoformans var gattii in an AIDS patient.
    Peetermans W; Bobbaers H; Verhaegen J; Vandepitte J
    Acta Clin Belg; 1993; 48(6):405-9. PubMed ID: 8128821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of DNA fingerprints in Cryptococcus neoformans.
    Varma A; Swinne D; Staib F; Bennett JE; Kwon-Chung KJ
    J Clin Microbiol; 1995 Jul; 33(7):1807-14. PubMed ID: 7665650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil.
    Rozenbaum R; Gonçalves AJ; Wanke B; Caiuby MJ; Clemente H; Lazera Mdos S; Monteiro PC; Londero AT
    Mycopathologia; 1992 Sep; 119(3):133-6. PubMed ID: 1435954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cryptococcus neoformans, var. neoformans, Cryptococcus neoformans var. gattii, causative agents of cryptococcosis].
    Swinne D; Lumbila M
    Bull Mem Acad R Med Belg; 1987; 142(2-3):238-48. PubMed ID: 3311260
    [No Abstract]   [Full Text] [Related]  

  • 18. Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in China.
    Fan X; Xiao M; Chen S; Kong F; Dou HT; Wang H; Xiao YL; Kang M; Sun ZY; Hu ZD; Wan Z; Chen SL; Liao K; Chu YZ; Hu TS; Zou GL; Hou X; Zhang L; Zhao YP; Xu YC; Liu ZY
    Clin Microbiol Infect; 2016 Oct; 22(10):887.e1-887.e9. PubMed ID: 27432767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital.
    Aguiar PADF; Pedroso RDS; Borges AS; Moreira TA; Araújo LB; Röder DVDB
    Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e13. PubMed ID: 28423088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
    Thompson GR; Wiederhold NP; Fothergill AW; Vallor AC; Wickes BL; Patterson TF
    Antimicrob Agents Chemother; 2009 Jan; 53(1):309-11. PubMed ID: 18955539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.